The Industrial Revolution of Drug Discovery

Chris Anderson is the co-founder and CEO of a new company, Adelphia. He says he wanted to create an industrial revolution in drug discovery. The company has been around for two years but just launched its second round of funding this week. It's now working with more than 100 companies across several industries including biopharmaceuticals as well as machine learning technology.